Versant Capital Management, Inc - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$4,000–1,091
+1374.3%
0.00%–
Q1 2019$0–74
-37.8%
0.00%–
Q4 2018$0–119
+60.8%
0.00%–
Q3 2018$0–74
+208.3%
0.00%–
Q1 2018$0–24–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders